DE3750180D1 - Laminin bindende peptidfragmente. - Google Patents

Laminin bindende peptidfragmente.

Info

Publication number
DE3750180D1
DE3750180D1 DE3750180T DE3750180T DE3750180D1 DE 3750180 D1 DE3750180 D1 DE 3750180D1 DE 3750180 T DE3750180 T DE 3750180T DE 3750180 T DE3750180 T DE 3750180T DE 3750180 D1 DE3750180 D1 DE 3750180D1
Authority
DE
Germany
Prior art keywords
laminine
binding peptide
peptide fragments
probe
aggressiveness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750180T
Other languages
English (en)
Other versions
DE3750180T2 (de
Inventor
Mark Sobel
Lance Liotta
Ulla Wewer
Michael Jaye
William Drohan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States, represented by S
Original Assignee
US Department of Commerce
Rorer International Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Commerce, Rorer International Holdings Inc filed Critical US Department of Commerce
Publication of DE3750180D1 publication Critical patent/DE3750180D1/de
Application granted granted Critical
Publication of DE3750180T2 publication Critical patent/DE3750180T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE3750180T 1986-09-26 1987-09-23 Laminin bindende peptidfragmente. Expired - Fee Related DE3750180T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/911,863 US4861710A (en) 1986-09-26 1986-09-26 Recombinant DNA clone encoding laminin receptor
PCT/US1987/002411 WO1988002407A1 (en) 1986-09-26 1987-09-23 Recombinant dna clone encoding laminin receptor

Publications (2)

Publication Number Publication Date
DE3750180D1 true DE3750180D1 (de) 1994-08-11
DE3750180T2 DE3750180T2 (de) 1994-11-03

Family

ID=25431000

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750180T Expired - Fee Related DE3750180T2 (de) 1986-09-26 1987-09-23 Laminin bindende peptidfragmente.

Country Status (7)

Country Link
US (1) US4861710A (de)
EP (1) EP0324788B1 (de)
JP (3) JP2533595B2 (de)
AT (1) ATE108188T1 (de)
CA (1) CA1305678C (de)
DE (1) DE3750180T2 (de)
WO (1) WO1988002407A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04502101A (ja) * 1988-08-31 1992-04-16 ダナーファーバー・キャンサー・インスティテュート ヒト・ラミニン結合タンパク質をコードする完全な長さのｃＤＮＡ
US5175251A (en) * 1989-05-04 1992-12-29 Sri International Antimetastatic peptides with laminin activity
CA2040099A1 (en) * 1990-05-01 1991-11-02 Mariano Barbacid Tyrosine kinase negative trkb
WO2000077201A1 (en) * 1999-06-15 2000-12-21 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)
WO2002020598A1 (en) * 2000-07-28 2002-03-14 Michael Andrew Mcguckin Mucin
US20030118585A1 (en) * 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
CA2502479A1 (en) * 2004-12-01 2006-06-01 Procyon Biopharma Inc. Laminin receptor binding molecule
EP2330122A1 (de) 2009-12-02 2011-06-08 Asklepios Kliniken Hamburg Gmbh OFA/iLRP-abgeleitetes modifiziertes Peptid
GB201700529D0 (en) * 2017-01-12 2017-03-01 Rogers April Laminin receptor peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4565789A (en) * 1983-04-04 1986-01-21 The United States Of America As Represented By The Department Of Health And Human Services Cell matrix receptor system and use in cancer diagnosis and management

Also Published As

Publication number Publication date
ATE108188T1 (de) 1994-07-15
JP2533595B2 (ja) 1996-09-11
JPH06107691A (ja) 1994-04-19
US4861710A (en) 1989-08-29
CA1305678C (en) 1992-07-28
JPH0880200A (ja) 1996-03-26
EP0324788A1 (de) 1989-07-26
JPH02500637A (ja) 1990-03-08
EP0324788B1 (de) 1994-07-06
WO1988002407A1 (en) 1988-04-07
DE3750180T2 (de) 1994-11-03
JP2825780B2 (ja) 1998-11-18
EP0324788A4 (de) 1990-03-28

Similar Documents

Publication Publication Date Title
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
DK1442058T3 (da) Peptider der er effektive til behandling af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
DK161015C (da) Blanding til anvendelse ved ekstern paavisning og lokalisering af en blodprop
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
DE69737788D1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
RU2001104349A (ru) Композиции и способы для терапии и диагностики рака предстательной железы
DE3750180D1 (de) Laminin bindende peptidfragmente.
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
DE69735020D1 (de) Verfahren zur Diagnose von Prostatakrebs
DE69021742D1 (de) Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck.
AP2000001917A0 (en) Gene encoding labyrinthin, a marker for cancer.
IL144129A0 (en) Methods and kits for sequencing polypeptides
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
ATE298003T1 (de) Ein tumorsuppressor namens ts10q23.3
WO2000023589A3 (en) Proliferation and apoptosis related proteins
ATE475710T1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
DE69739449D1 (de) Invasionsinhibitoren zur verwendung in der wundheilung und krebsbehandlung
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
IL155687A0 (en) Polynucleotides encoding hlrrsi1 polypeptides
NZ502270A (en) Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: THE UNITED STATES OF AMERICA, REPRESENTED BY THE S

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee